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Abstract
Recent studies suggest that besides oncogenic capacity, HPV could have etiological 
role on infertility, but more evidence is necessary to confirm these results. We pres‐
ent in this chapter the microbiological and clinical outcome of 104 infertile women 
aleatory selected, from northeast of Mexico: 84.6%, with genital infection (GI) by mul‐
tiple germs: Chlamydia trachomatis (Ct) [86.5%], HPV [49%], Ureaplasma urealyticum 
(Uu) [47.11%] and Mycoplasma hominis [35.57%]. Significant association (P ≤ 0, 05) was 
observed between the HPV presence and Uu diagnosis, assisted‐reproduction unsuc‐
cessful like previous treatment, cervical cytology with inflammatory process, multiple 
sexual partners, white‐dense‐mucous, secretion into the vagina, and HPV diagnosed 
in early years. The more frequent genotypes of HPV present in the infertile women 
studied were 6/18/16/58/11 and 68. In 60% of them, more than two genotypes were 
founded. The most frequent associations of high‐risk HPV (HPVhr) were 16/18, 16/58, 
16/33, 16/52 and 18/58. Considering the isolate or combined presentation of HPVhr, 
79.5% of these women would have a potential to develop cervix carcinoma. GI by 
HPV/Uu/Ct affects the fertility. Infertile women with GI that include these microor‐
ganisms with probed (HPV/Ct) or suspicious carcinogenic effect (Uu) would be con‐
sidered a group of high risk for cervical cancer.
Keywords: genital infection, HPV, Chlamydia trachomatis, Ureaplasma urealyticum, 
Infertility, risk for cervical cancer
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1. Introduction
At present, reproductive failure affects to a great population. Human infertility is defined by 
World Health Organization, like the absent of conception and outcome of healthy baby borne, 
after 1 year of unprotected intercourse. Infertility is a health complex problem with low qual‐
ity life for the couples. Estimations on 2010 referred 1.9 and 10.5% of primary and secondary 
infertility, respectively, on women at reproductive age (20–40 years old). A high prevalence 
of fertility health is documented in South of Asia, Medium East, Central Europe, East Europe, 
and Central Asia [1].
Genitourinary unspecific infection is associated with unexplained infertility, subfertility, obstet‐
ric and gynecologic complications that not have known clear etiology for several decades like 
recurrent abortion, premature delivery, placenta dysfunction and preeclampsia [2, 3]. As well, 
assisted reproduction treatment for infertility had been associated with genital infection [4–7]. 
Specific treatment for genital infection is recommended to improve the successful of in vitro fer‐
tilization an embryo implantation [8, 9]. The low age of sexual activity initiation and with mul‐
tiple sexual partners is a recognized risk factor for sexually transmitted genitourinary infection, 
but the absent or subtle clinical manifestations prevent the opportune treatment and persisting 
infection for long time and thus may exert detriment on the reproductive function [10].
Besides the still controversial participation of HPV on fertility and obstetric complications, 
the major bacteria implicated for a long time are C. trachomatis, and other atypical bacteria 
treated in next section: U. urealyticum, M. hominis, that were considered for a long time an 
improbable cause of female internal genital infection, were isolated from endometrial tissue 
and material obtained by hysteroscopy and laparoscopy procedures, in women with tubary 
obstruction, hidrosalpinx, and adherence syndrome [11–15]. In recent years, another species of 
Mycoplasmataceae, M. genitalium, has been considered an emerging sexually transmitted infec‐
tion that exerts damage in female genital tract and is implicated in fertility problems [16–18].
2. Human papillomavirus
2.1. Classification
HPV belongs to Papoviridae family microorganism and comprises a group of approximately 
200 small DNA viruses. According to its tissue tropism, HPV has been classified like Alpha 
HPV that affects epithelial mucosae and is subclassified into high risk and low risk of carcino‐
genic potential Beta, gamma, nu and mu. HPV has more potential to affect cutaneous epithelia 
and more associated with papilloma and external warts and had been associated with no 
melanocytic skin carcinoma [19, 20].
2.2. Epidemiology
The HPV infection has an epidemiologic importance. Registered prevalence is influenced 
by diagnostic test applied, the number and age of individuals of studied population, the 
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 geographic region studied [21]. Nevertheless, actually are considered the most common sexu‐
ally transmitted viral infection worldwide, present in 11–12% of population and are 14 mil‐
lion people infected by first time each year. The incidence of HPV infection in the United 
States is one of higher, as 44.8%, and is present principally in women 20–24 years old [22]. In 
Mexico from 2005 to 2010, urogenital candidiasis and HPV infection present an incidence of 
12.3/100,000 habitant between 15 and 24 years old and were higher between 20 and 24 years 
old. In this country had been estimated that toward 2050, there are not a clear tendency to 
diminish of the HPV infection. This situation is very worrying due to the potential malig‐
nancy of the lesions [23]. On the records of National Institute of Statistic and Geography of 
Mexico, were informed that 4417 women died by cervical cancer, in 2013 [24].
2.3. Biomedical importance
HPV infect principally undifferentiated keratinocytes into de basal level of stratified squa‐
mous epithelia, from mucous genital and oropharyngeal epithelia cutaneous and, as well 
as glandular cells of endocérvix [25–27]. HPV had been recognized as definitive anogenital 
carcinogen for male and female, mainly in uterine cervix cancer [28], alone or in combina‐
tion with other germs [29]. Some estimations show that the presence of HPV represents 12 
more opportunities to develop cervical cancer than general population [30] and the HPV 
infection the most important between the factor risk for cervical cancer [21]. Recently, HPV 
was associated, lung cancer [31–34] to larynx and pharynx carcinoma that their incidence 
are increasing in the last years [35, 36]. The global incidence of head and neck squamous 
cells and cervical cancer is similar; infection at both sites is strongly associated with sexual 
behavior: similarities in chromosomal aberrations, gene expression, and methylation and 
micro RNA profiles between Positive HPV head and neck squamous cells and cervical 
cancer. All of these observations were referred as argue to carry out comparative epide‐
miologic study of HPV infection and associated with carcinoma of head and neck and 
cervical cancer [37].
2.4. Their role in reproductive failure
Although is well known than many authors are interested to search carcinogenic roll of HPV, 
there are only a few studies about the effect of HPV infection on human reproduction [38–41]. 
There is evidence showing the adherence of HPV to the equatorial segment of sperm cell [42]. 
Epidemiologic data about the infection by HPV in infertile men associated high levels of semi‐
nal leukocytes, with altered movement and morphology of head sperm, with the HPV infec‐
tion [43–45]. Previously, experimental studies had been demonstrated chromosomic damage 
in HPV infected sperm, depending of genotypes 16 and 3 [46, 47]. An association has been 
found between cervical HPV of high risk and premature membrane rupture and preterm 
new borne [48–50]. The genital infection by more than one genotype of HPV was higher in 
recurrent early lost pregnancy, and HPV was identified in placenta tissue of preterm delivery 
by preeclampsia [41]. The frequency of cervical HPV infection and high‐grade lesion was 
higher in women that have indicated assisted reproduction than general population [6] and 
successful of assisted reproduction were affected by the presence of HPV [5, 7]. The HPV 
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transmission from mother to child in utero was informed in several investigations [51–54]. 
These authors remark the risk to appear papillary lesions in oropharynx and larynx of new 
born from mothers infected by HPV.
3. Chlamydia trachomatis
3.1. Biology and classification
The family Chlamydiaceae consists of two clinically important genera, Chlamydia and 
Chlamydophila, with three species responsible for human disease: Chlamydia trachomatis, 
Chlamydophila psittaci, and Chlamydophila pneumoniae [55]. C. trachomatis, as all the members 
of the family Chlamydiaceae, is an obligate intracellular parasite whose developmental cycle 
occurs within a eukaryotic host. Infection of eukaryotic host cells is initiated by the metaboli‐
cally inactive and the infectious elementary bodies (EBs). Through largely unknown mecha‐
nisms, EBs attach to and induce their internalization by host cells. Within the first few hours 
post infection, EBs differentiate to the larger and more pleomorphic reticulate bodies (RBs), 
which are metabolically active, noninfectious, and replicative. At the end of a successful 
developmental cycle, the cell lyses, releasing the EBs [56, 57].
3.2. Medical relevance
Chlamydia trachomatis is the most prevalent sexually transmitted bacterial infection, recog‐
nized worldwide, which causes a wide spectrum of diseases, including salpingitis, endo‐
metritis, and uterine, cervical lesions with scarring process, which often causes infertility in 
women [58]. Serotypes D‐K of C. trachomatis has an etiologic relation to pelvic inflammatory 
disease; it has been isolated from superior genital tract in a quarter of women with pelvic 
inflammation and is possible that chronic process would be in relation to ovarian cancer [59]. 
The role of C. trachomatis with regard to inducing male factor infertility is a matter of debate. 
Chlamydial infection could potentially exert a strong influence on male infertility, as it is the 
main cause of urethritis and accessory gland inflammation in men. Sequelae of ascending 
infections might be occlusions in the canaliculi system of the genital tract, damage of the epi‐
thelial cells involved in spermatogenesis, and immunoreaction with the production of anti‐
sperm antibodies [60, 11]. Also, the relationship of C. trachomatis infection with semen quality 
and sperm morphology is still controversial [61, 62]. In men, are documented that Chlamydia 
trachomatis is responsible of epididymitis, orchitis, prostatitis and urethritis [63–66]. Then 
more, there are many evidence of that this infection cause sperm damage with low motility, 
altered morphology, and diminish of sperm concentration, with detriment of male fertility 
[67–71]. Sexually transmitted infections are hypothesized to play a role in the development 
of prostate cancer, perhaps due to inflammation‐induced oncogenesis [71]. Eventually, more 
evidence supports this affirmation. An investigation to evaluate the possible role of Chlamydia 
trachomatis in the pathogenesis of prostate cancer assessed the presence of this bacterium in 
prostate biopsies of patients with prostate cancer, patients with benign prostatic hyperplasia 
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(BPH) and control subjects. Tissue sections were analyzed using a direct fluorescent‐anti‐
body (DFA) assay. When proliferative areas were compared, C. trachomatis was most fre‐
quently detected in prostate cancer group that in BPH patients (p = 0.006). In inflammation 
areas, C. trachomatis was most frequently detected in prostate cancer patients that in control 
subjects (p = 0.008). These data suggest an association between the presence of C. trachomatis 
and prostate cancer [72].
4. Mycoplasmataceae Genus
4.1. Biology and classification
Mycoplasma are microorganisms derived from Gram‐positive bacteria characterized by: 
streamlined and very small genome, the absence of a cell wall, requiring cholesterol for mem‐
brane function and growth, and displaying genetic economy that determine a strict depen‐
dence of the host for nutrients and refuge [73, 74]. They have a parasitic lifestyle, invading 
target cells and existing and replicating for extended periods intracellularly [75]. From 200 
species established into class Mollicutes, six of them: Ureaplasma urealyticum, Mycoplasma homi‐
nis, Mycoplasma genitalium, Mycoplasma primatum, Mycoplasma spermatophilum and Mycoplasma 
penetrans have like their main site of colonization, the genital tract [76]. These microorganisms 
can be commensal in low genitourinary tract of sexually active men and women and can 
live in close relationship to mammalian cells. Nevertheless, they may cause disorders and 
pathologies associated with infertility: non‐gonococcal and non‐chlamydial, epididymitis, 
urolitiasis, as well with reproductive problems and infertility [77–84].
4.2. Medical relevance
Gnarpe and Friberg in early seventies informed for the first time a high percentage (85%) of 
infertile patients with Ureaplasma urealyticum isolated from semen by specific culture, com‐
pared to low percentage (22%) in fertile men. Then, these authors showed by scanning elec‐
tron microscopy, Mycoplasma adhered to sperm tail [85]. Similar observation was done in 
the following years by different authors [86–90]. The use of PCR techniques confirmed the 
presence of Ureaplasma urealyticum in seminal samples of subfertile men with sperm altera‐
tions [62, 91, 92]. Since two before decade, had been affirm that Mycoplasma have carcino‐
genic potential due to the long latency an infection chronicity that may induce malignant 
cellular transformation [93]. Recently, experimental studies demonstrated induction of genic 
expression altered in prostatic and cervical cells and progression to malignant transforma‐
tion [94, 95]. Mycoplasma hominis and Mycoplasma hyorhinis, a mycoplasma frequently present 
in patients with AIDS, induce malignant transformation with increased karyotypic entropy, 
chromosomal aberrations and polysomy, in BPH‐1 cells, after 9 months that were infected 
with these germs [96]. These observation had been supported a relationship between prosta‐
titis and cancer, in etiologic association referred in 2002 [97].
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5. Mechanism of genital coinfection by HPV, chlamydia trachomatis and 
mycoplasmas
The cervical overlaying columnar epithelia can be invaded by Ureaplasma urealyticum and 
Chlamydia trachomatis that produce severe inflammatory response, with discharge of exuda‐
tive secretions and clinical signs and symptoms [98, 99]. Nevertheless, usually the appro‐
priated diagnostic test will not be applied, and the treatment generally is unspecific. The 
presence of inflammatory cells in the genital ducts enhances the adherence of virus [100, 101], 
and Chlamydia trachomatis has been considered an enhancer to the entry of human immuno‐
deficiency virus and HPV, the only one germ directly associated with the etiology of cervi‐
cal cancer [101–104]. Several studies have demonstrated an association between Chlamydia 
trachomatis and a high risk HPV persistence [105, 106]. A study realized by Paba et al., (2008), 
in patients with intraepithelial neoplasia or cervical cancer, confirmed the association of 
Chlamydia trachomatis and multiple high risk HPV persistence, and like a consequence of viral 
integration, inhibition of cell apoptosis, overexpression of E6/E7 oncogenes and cellular trans‐
formation [107].
6. Our experience
6.1. Studies on male infectious factor of infertility
Our group has reported different studies in couples with infertility of unknown etiology, from 
northeast Mexico. In that patients with spontaneous and recurrent abortion and failure in 
assisted reproduction treatments, was frequently detected the presence in seminal fluid, urethral 
swab and cervix and vagina secretions, of Chlamydia trachomatis and Ureaplasma urealyticum, and 
Mycoplasma hominis. The diagnosis of Chlamydia trachomatis was made by direct immunofluores‐
cence, the gold standard for this microorganism for a long of time. For detection of Ureaplasma 
urealyticum and Mycoplasma sp., we practiced specific media culture, considered too, the gold 
standard. In morphologic seminal analysis, we described the presence of elementary bodies 
and inclusion vacuoles of Chlamydia and bacterial particles similar to Mycoplasmas, inside the 
cytoplasm, adhered to the principal piece and into the middle piece of the sperm [108].
A pattern of structural sperm alteration and inflammatory reaction with sperm phagocyto‐
sis, by leucocytes and macrophages, were described by semi thin section at light microscopy 
and thin section by transmission electron microscopy [109–113]. Beside this the infectious 
process result a diminish motility, vitality, linear movement and sperm concentration. These 
seminal parameters were associated with high levels of sperm chromatin fragmentation (SCD 
test), and high levels of reactive oxygen species (ROS) detected by NBT test. The antibiotic, 
antioxidant and drugs against the inflammation treatment determine the reduction of bacte‐
riospermia, increase percentage of normal sperm, especially from acrosome damage, middle 
piece flagellum and nuclear defects. After 6 weeks of treatment, the probability of outcome of 
pregnancy with healthy newborn increased, and seminal parameters of predictive value were 
chromatin fragmentation, bacteriospermia and head sperm anomalies [114–117].
Fundamentals of Sexually Transmitted Infections186
6.2. Studies on female infectious factor of infertility
After confirming that a very high percentage of couples in northern Mexico with incapacity to 
procreate, have Chlamydia trachomatis and Ureaplasma urealyticum infections in the ducts and 
organs of the seminal tract, associated with detrimental damage of fertilization capacity of 
the sperm, we studied the endometrium histopathology and endometrialis bacteria. Although 
endometritis is included into the internal genital infection, present in a high percentage of 
infertile couples, the study of endometrial biopsy is out of the diagnostic routine evaluation of 
infertility female factor. Microscopic analysis was performed on paraffin embedded and H&E 
stained tissue sections, observed at 1000X. In all the cases, it was possible to recognize, the 
presence of bacterial particles, identified according to their morphology, such as Chlamydia 
or Ureaplasma, which were previously diagnosed in genital secretions. The most frequent 
histopathologic findings at the endometrial tissue were interstitial edema (93%), lymphocytic 
and polymorphonuclear subepithelial infiltrate (72%) and in 48%, plasmocytic subepithelial 
infiltrate. The cell denudation of the lining epithelia was observed in 69% of biopsies, and in 
62% of them, intracytoplasmic vacuole of epithelial cells, known as spongiosis, was observed. 
In a low percentage of cases, intraepithelial inflammatory cells (lymphocytes and polymor‐
phonuclears) were found at the endometrium, both lining and glandular epithelia. Germinal 
center of inflammatory cells in the connective stroma also was observed. The concluding 
results of this study showed the invading endometrium with Chlamydia trachomatis and 
Ureaplasma urealyticum that were present too, into the mucus of uterine cavity and cervical 
duct. In view of glandular and stromal changes, inflammatory reaction and presence of bac‐
teria into the stromal tissue and glandular and lining epithelia, endometritis due to Chlamydia 
trachomatis and Ureaplasma urealyticum, should be considered like an adverse condition to the 
female fertility as well implantation and normal embryo development. The clinician must 
consider the study of endometrial biopsy in all patients that need evaluation for infertility, 
even more if signs and symptoms of internal genital infection or chronic inflammatory pro‐
cess are present. Early diagnosis of genital infection and laboratory test performance looking 
for Chlamydia trachomatis and Ureaplasma urealyticum and its corresponding treatment could 
be prevent reproductive failure and scarring injuries and maybe can improve the results of 
reproduction treatments [118, 119]. While male genital infection by Chlamydia trachomatis 
and Ureaplasma urealyticum is generally asymptomatic, the women have a variable signs and 
symptoms of the sick, and clinical improvement is easier to appreciate; in male, their low 
and subtle clinical signs of infection and the treatment results can be see only by the study 
of seminal parameters in relation to the infection. For some years, we have focused on the 
investigation of the clinical and pathogenic aspects of the internal genital infections as well 
as the integral therapeutic management of male and female reproductive pathologies named 
as treatment of “binomials gineco‐andrologic” of the infectious factor of Infertility [120, 121].
6.3. Study of HPV in infertile couples
In addition of sexually transmission of Chlamydia trachomatis and Ureaplasma urealyticum, 
along the clinical evaluation, is necessary to be in alert to another sexually transmitted germ. 
This chapter focuses on the results of the first work that we carried out about the importance 
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of the presence of HPV in the population with infectious factor of infertility. The aim of this 
analysis was to establish the HPV and genotype prevalence, the relationship of HPV presence 
with other microorganism, and to describe clinical findings of the studied group of patients.
6.3.1. Patients, material and methods
6.3.1.1. Study population
For the present analysis, samples of mucous secretion from cervix and vagina and endocervi‐
cal scrapes of 104 women randomly selected women, from patients attended at private clinic 
in Monterrey, México, for infertility and genitourinary infection since 2003–2014. Patients 
were recruited by verbal invitation at the time of consultation. They gave voluntary authori‐
zation, by Informed consent, to use the clinical data and results of the laboratory test for sta‐
tistical analysis. Ethical issues were in accordance with the Helsinki Declaration and endorsed 
by the Ethics Committee of our institution (PA15‐001). All selected patients had polymerase 
chain reaction (PCR) test for HPV in genital secretions and were tested by direct specimen 
test Kit for Chlamydia trachomatis detection (MicroTrak; Trinity Biotech, Wicklow, Ireland); the 
isolation of Ureaplasma urealyticum and Mycoplasma hominis was done using the Mycoplasma 
IST kit (BioMerieux, Marcy L’ Etoile, France). For any other microorganism, we applied gen‐
eral culture.
6.3.1.2. Clinical assessment
An infertility medical history was taken and recorded on a standardized form by a single 
experienced clinician, who also performed external genital, vaginal exploration, pelvic 
examinations and realized the sampling of genital secretions. The data obtained from medi‐
cal file were: demographic parameters, history of fertility and infertility, gestational losses 
and obstetric complications, treatment of infertility problems, history of cervical lesions, and 
surgical procedures, result of previous cervical‐vaginal cytology Pap smears, signs and symp‐
toms of genitourinary infections and pathological data of the cervix and vagina examina‐
tion. At subjective appreciation, the clinical parameters were considered for semiquantitative 
record: low, medium, and high or abundant.
6.3.1.3. HPV DNA extraction and genotyping
For the extraction and purification of DNA from cervical samples, 100 μL of the cell suspen‐
sion previously prepared was used. Silica extraction columns (Nucleospin® Blood, Machery‐
Nagel GmBH & Co., Germany) were used under the manufacturer’s instructions. During the 
12 years covered by this study, the technology for HPV diagnosis was changing. For this 
reason, different techniques were applied depending on the time when the patient arrives 
for medical treatment. In 34 patients, molecular detection of HPV‐AND was carried out by 
PCR‐Multiplex that detect 4–12 genotypes; for 36 patients, secretions from the cervix and 
vagina were tested for HPV capillary electrophoresis using “Applied Biosystems 3130 series 
genetic analyzer systems” and the software GeneMapper, which diagnostic 14–19 genotypes 
high and low risk. Molecular detection of ADN from HPV was done in the 36 patients by 
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Dual Priming Oligonucleotide, more specific and that detect 14–19 genotypes of HPV and in 
the 34 last patients in situ Hybridization with oligo specific probes to identified 20–28 HPV 
genotypes.
6.3.1.4. Statistical analysis
Absolute frequency of qualitative parameters is expressed in percentages. For quantitative 
variable was calculated media and, or median as well standard deviation. Sensitivity, specific‐
ity, positive and negative predictive values were calculated using (2 × 2) contingency tables. 
The association between clinical results and HPV and the association between other micro‐
organisms present were calculated with Fisher’s exact test. For all tests, the significance level 
was P ≤ 0.05 and power of (1‐β) = 80% for two‐tail. The statistical software used was SPSS 
version 17 for Windows (SPSS Inc.)
6.3.2. Results
From 690 infertile couples attended from 2003 to 2012, the aleatory selected sample of 104 
female partners was representative, according to medium probability ponderation of 48% for 
the different genotypess, that was estimated based in some reports [122]. A total of 104 female 
partners from couples with genitourinary infection were included in this study. Primary 
infertility was present in 65 couples and secondary infertility in 13 couples. The median age 
of the patients was 34 years (range, 22–55 years). The microorganisms identified on the group 
studied are C. trachomatis (86.5%), HPV (49%), U. urealyticum (47.11%), M. Hominis (35.57%), 
E. coli (20.2%), C. Albicans (17.3%) and S. faecalis (10.6%). In a high proportion of the vaginal 
samples, microbiota vaginal was reduced or absent in a (76.9%) and 86% have more than one 
pathogen germs. C albicans was present like solitary microorganism in 17.3% as well HPV was 
the only identified germ in one patient. Statistical analysis established positive correlation 
between HPV and U. urealyticum (p = 0.05) and decreased microbiota (p = 0.001).
The distribution of C. trachomatis was similar in the positive and negative to HPV group 
(Figure 1).
Between the clinical parameters taken into account for this investigation, some of them pre‐
sented statistics correlation to the presence of HPV: the presence of more than one sexual part‐
ner (p = 0.05), genitourinary infection symptoms (p = 0.01), white mucous vaginal secretion 
fluxing from the uterine duct (p = 0.05), failure in assisted reproduction previously carried out 
(p ≤ 0.0001), and previous HPV infection diagnosed by suspicious lesion or cytological exam 
(p ≤ 0.0001) was in association to HPV (Table 1). For Microbiota vaginalis, the relationship to 
the presence of HPV was proportionally inversed.
Prevalent genotypes of HPV detected in the infertile patients studied group were; HPVar 6 
(19.2%), HPVhr 18 (12.5%), HPVhr 16 (11.6%), HPVhr 58 (11.1%), HPVhr 52 (7.1%), HPVlr 11 
(6.7%) and HPVhr 68 (7.5%). Thirteen different genotypes of PVH were detected in low fre‐
quency. These data are concentrated on Table 2. To consider the percentage of this frequency, 
it is necessary to remember that the results depend on the number of HPV search in each one 
of the three different tests applied that was not equal for all patients.
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Combinations of more than one HPV genotypes were detected in 60% on the studied samples. 
From them 46.3% were the following associations between high risk for cancer HPV: 16/18, 
18/58, 16/33, 16/52 and 18/52. In a similar percentage (44.8%) of women, low risk for cancer, 
principally HPV 6, was detected in combination with high risk HPV: 18, 52, 16 and 39. As well, 
we observed that three to five different HPV genotypes were present in 23.5% of the positive 
group infertile patients (Figure 2).
According to the results of this study, a total of 79.5% of positive HPV group of patients, pre‐
sented one or more high‐risk genotypes, and considering the statistical association between 
the positivity to HPV and the clinical history of previous HPV infections, this condition may 
represent a persistent infection or a reinfection. Consequently, we consider convenient a rec‐
ommendation to take in account women with reproductive failure, like a group of risk of 
cervical cancer. There was statistical association between the positivity to HPV to clinical his‐
tory of previous HPV infections. Would be very important, the simultaneously presence with 
Ureaplasma urealyticum, and Chlamydia trachomatis, sexually transmitted germs with suspi‐
cious carcinogenic potential, in a population in reproductive age, as we observed in this study.
With the results obtained from this study, it was not possible to establish an association between 
the abortions presented in 28 of the studied women, and the positivity to HPV. Nevertheless 
for future studies that include a high number of patients, is may be important to observe that 
low risk to cancer genotypes 6 and 11, were present in a high prevalence in this investigation, 
and their importance on the results of inseminations, in vitro fertilization and gestational loss, 
and are not defined now a days. Finally, our data confirm the  recommendation to investigate 
HPV before to carry out in vitro fertilization, in view of the high frequency of failure of this 
treatment of infertility, when HPV is present.
Figure 1. Microorganism identified into the cervix and vagina secretions of 104 female partners from couples with 
genitourinary infection. The most frequent bacteria in the genital sample of infertile women studied were Chlamydia 
trachomatis. However, if we considered that Ureaplasma urealyticum and Mycoplasma hominis belong to the same genus: 
Mycoplasmataceae, the presence of these bacteria, result of major importance in this group.
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Total of cases HPV positive HPV negative P
N % N % N %
HPV previous 
diagnosis




33 32.0 21 41.2 12 23.1 0.05
Active genitourinary 
infection
67 64.4 39 76.5 28 52.8 0.01
Only one partner 67 64.4 28 54.9 39 73.6 0.05
≥2 sexual partner 37 35.6 23 45.1 14 26.4 0.05
Unsuccessfully FIV/
ICSI
15 100 11 73.3 4 26.7 0.002
White, dense mucus 
secretion




49 47.1 29 56.9 20 37.7 0.05
Absence of vaginal 
microbiota
55 52.9 24 47.1 31 58.5 0.03
Diminished vaginal 
microbiota
25 24.0 17 33.3 8 15.1 0.03
The most frequent bacteria in the genital sample of infertile women studied were Chlamydia trachomatis. However, if 
we considered that Ureaplasma urealyticum and Mycoplasma hominis belong to the same genus: Mycoplasmataceae, the 
presence of these bacteria, result of major importance in this group.
Table 1. Microbiological and clinical data associated with HPV.
HPV genotype 
identified
Risk for cancer Patients studied for genotype Positive result
N % N %
6 Low 104 100 20 19.2
16 Alto 103 99 12 11.6
18 High 104 100 13 12.5
58 High 72 69.2 8 11.1
52 High 98 94.2 7 7.1
11 Low 104 100 7 6.7
31 High 87 83.7 5 5.7
33 High 72 69.2 5 6.9
68 High 67 64.4 5 7.5
66 High 67 64.4 3 4.5
51 High 98 94.2 3 3.1
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The following description will give an illustration of some of cases included in this study 
resume of microbiologic and gineco obstetric data are included at the Figures 3–5.
Case 2. Women 34 years, previously treated with five intrauterine inseminations and three 
in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI). This patient had been 
treated repeatedly too, for genitourinary infection, unsuccessfully. After abnormal findings 
in a colposcopy, and histopathologic diagnosis of koilocyte in a cervix biopsy the clinician 
decide to practice hysterectomy, principally to solve the recurrent infections. One year later, 
these women required medical assistance due to severe signs and symptoms of genitouri‐
nary infection. In the vaginal sample were presented HPV 18, 35, 39, 51, 56, 66 y 74 (Figure 3). 
Case 3. Woman of 29 years old attended by primary infertility of unknown etiology and had 
been treated two times by assisted reproduction, with negative results. At the time of her 
arrive to the specially clinic, she referred previous result of ASCUS in PAP and signs and 
symptoms of genitourinary infection: dysuria, pelvic pain, abnormal menstrual bleeding, 
and a fluxing of white secretion from the vagina. At genital exploration, hypertrophy and 
erythema of cervix and papillary lesion at vaginal wall were found. The secretion of cervix 
and vagina was positive to C. trachomatis, U. urealyticum and C. albicans. PCR detected geno‐
types 16, 31, 33, 52, and 54 (Figure 4).
Case 3. Female 31 years, with two pregnancy loss of the first trimester, in both were diagnosed 
by ultrasound a chorionic vesicle without embryo. This patient did not have any fertility treat‐
ment previously. She had some PAP inform with inflammation but in one of them was diag‐
nosed metaplastic changes. Genital infection was clinically diagnosed, and multi‐microbial 
infection was detected in samples of secretions. (Figure 4). Case 4. A 37‐year‐old woman, who 
had a child without fertility treatment and did not have a second pregnancy, despite having 
no contraceptive treatment. This patient required medical assistance for chronic infection that 
was resistant to many treatments implemented previously. In this case were found HPV 44 
HPV genotype 
identified
Risk for cancer Patients studied for genotype Positive result
N % N %
42 Low 66 63.5 2 3
39 High 69 66.3 3 4.3
59 High 69 66.3 1 1.4
45 High 73 69.2 1 1.4
35 High 73 69.2 1 1.4
71 Low 70 67.3 1 1.4
61 Low 69 66.3 1 1.4
55 Low 63 60.6 1 1.6
81 Low 1 1 1 –
Table 2. Prevalent genotypes of HPV detected by PCR in secretions of cervix and vagina of infertile women studied 
group.
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and HPV 52 in association to C. trachomatis, U. urealyticum that eventually may be an etiologic 
association to secondary infertility of this case. Then more, S. faecalis and E.coli were present 
as part of the microorganism found in genital secretions. Lactobacillus acidophilus was absent 
(Figure 5). Case 5. Another patient that not received infertility treatment, but do not have a 
baby, even to be active sexually and do not have protection contraceptive. This woman suffers 
urinary symptoms since 2 years ago, and clinical signs and symptoms of vaginal recurrent 
infection, resistant to previous treatments. The diagnostic test applied to vaginal and cervical 
fluids was positive to one of the most common HPV associations: 16 and 18, but HPV 39, C. 
trachomatis, U. urealyticum and C. albicans were part of the multiple germs infection (Figure 5).
Figure 2. HPV genotyping results: Combinations of HPV. The number inside the square represents the patients with at 
least two different genotypes HPV detected in cervical and vaginal secretions of the women studied. Inside the square 
is the number of cases identified with the combined presence in the sample of cervical secretion of different Genotype 
HPV. For example: 4 cases have a combination of 16 and 18 genotypes of HPVhr; another 4 cases have simultaneously 
HPVhr 16 and 58.
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Figure 3. Infertile women with chronic genitourinary infection, and failure in assisted reproduction. Case 1. The patient 
was treated by hysterectomy due to persistent infection, after several fruitless treatment of assisted reproduction for 
primary infertility. The images illustrate clinical, histopathological and HPV test in vaginal secretions. (A) Abnormal 
colposcopy; (B) koilocyte was found in the cervix biopsy; (C) arrow shows lesion on vaginal fundus; (D) results of PCR 
and HPV genotyping of vaginal secretions. Multiple HPV were present, except the 74 of unknown significance, all 
correspond a high risk for cancer genotype.
Figure 4. HPV genotypes combinations associated with genitourinary infection by multiple microorganisms.
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7. Concluding remarks
This is a study carried out by aleatory selection of 104 infertile women attended by repro‐
ductive failure and genital infection; the main objective was to establish the relationship of 
HPV presence, with other microorganism and the genotype of HPV detected in this group of 
infertile women. All patients authorized the use of clinic and laboratory analysis data from 
her cervical and vaginal samples, to realize statistical analysis and sign an informed consent. 
The clinical parameters considered were: signs and symptoms of infection disease, results 
of previous assisted reproduction treatments, and the presence of previous abortions. These 
data were compared to genotype HPV present, and the diagnosis of others germs by labora‐
tory test included direct investigation with immunofluorescence monoclonal antibodies to 
Chlamydia trachomatis, and bacterial cultures, included selective media to U. urealyticum, M. 
hominis. The microorganisms identified on the group studied are C. trachomatis (86.5%), HPV 
(49%), U. urealyticum (47.11%), M. Hominis (35.57%), E. coli (20.2%), C. Albicans (17.3%) and S. 
faecalis (10.6%). In a high proportion of the vaginal samples, microbiota vaginal was reduced 
or absent in a (76.9%) and 86% have more than one pathogen germs. C albicans was present 
like solitary microorganism in 17.3% as well HPV was the only identified germ in one patient. 
Statistical analysis established positive correlation between HPV and U. urealyticum (p = 0.05), 
and decreased microbiota (p = 0.001). The distribution of C. trachomatis was similar in the posi‐
tive and negative to HPV group.
Figure 5. HPV genotypes combinations associated with genitourinary infection by multiple microorganisms in infertile 
patients.
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In this study, more than one sexual partner (p = 0.05), genitourinary infection symptoms 
(p = 0.01), white mucous vaginal secretion fluxing from the uterine duct (p = 0.05), failure 
in assisted reproduction before carry out, and previous HPV infection diagnosed by suspi‐
cious lesion or cytological exam (p ≤ 0.0001) were in association to HPV. Prevalent geno‐
types of HPV detected in the infertile patients studied group were HPV six (19.2%), HPV 18 
(12.5%), HPV 16 (11.5%), HPV 58 (7.2%), HPV 52 (6.7%), HPV 11 (6.7%) and HPV 68 (7.5%). 
Combinations of more than one HPV genotypes were detected in 60% on the studied samples. 
From them, 46.3% were the following associations between high risk for cancer HPV: 16/18, 
18/58, 16/33, 16/52 and 18/52. In a similar percentage (44.8%) of women, low risk for cancer, 
principally HPV 6, was detected in combination with high risk HPV: 18, 52, 16 and 39. As well, 
we observed that three to five different HPV genotypes were present in 23.5% of the positive 
group infertile patients. According to the results of this study, a total of 79.5% of positive HPV 
group of patients, presented one or more high risk genotypes, and considering the statistical 
association between the positivity to HPV and the clinical history of previous HPV infections, 
this condition may represent a persistent infection or a reinfection. Consequently, we consider 
convenient a recommendation to take in account women with reproductive failure, like a 
group of risk of cervical cancer. With the results obtained from this study, was not possible 
to establish an association between the abortions presented on 28 of the studied women, and 
the positivity to HPV. Nevertheless for future studies that include a high number of patients, 
is may be important to observe that low risk to cancer genotypes 6 and 11, were present in a 
high prevalence in this investigation, and their importance on the results of inseminations, in 
vitro fertilization and gestational loss, still not defined now a days.
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